About Us - Priority Healthcare Consulting

predictive market analysis

About Us | Our Team

We provide exceptional quantitative market research, leveraging our internal experts who have spent their entire careers in pharmaceutical market research. We uncover barriers, risks, and opportunities for your therapeutic product, predict market share with our proprietary forecasting method, and provide strategic direction on how to maximize your market share within that market. We are highly experienced market researchers who deliver high-quality results and exceed expectations on every project.

Seamus Cole, Lead Consultant

Seamus Cole has over eight years in healthcare consulting services, focused on quantitative and qualitative analysis in the pharmaceutical market research industry. He has advised over sixty commercial manufactures on a wide range of projects with expertise in patient journeys, forecasting market demand, projecting market access coverage, obtaining favorable coverage, and payer/patient/physician marketing optimization.

Derek Arnold, Head of Market Access Insights and Affordability Solutions

Award-winning pharmaceutical executive with 30 years of experience leading market access, patient affordability and distribution / trade strategies. Expertise includes developing and executing winning Product / Company “Value Propositions” to Payers / PBM’s and GPO’s resulting in Customer adoption and Formulary / Medical Policy access. Proven success creating and executing complex payer contracting for branded medications across commercial, Medicare, and Medicaid markets.

Biosimilar Launch Strategy in the U.S. and Emerging Markets

We are entering one of the biggest biosimilar waves in history, both in the United States and across emerging markets, with more than 200 billion dollars in biologic drugs expected to lose exclusivity over the next few years.

Market Access Payer Messaging Strategy: DOs and DON’Ts of a Successful Launch

Most drug launches fail at the payer level not because of price but because the story is not told clearly. Every important launch needs a thoughtful strategy to communicate a drug’s benefits to payers and give them a clear rationale for why it should be included on formulary.

Priority Healthcare Consulting

About Us | Our Team

Our Team

Seamus Cole, Lead Consultant

Derek Arnold, Head of Market Access Insights and Affordability Solutions

Latest Articles

Biosimilar Launch Strategy in the U.S. and Emerging Markets

Market Access Payer Messaging Strategy: DOs and DON’Ts of a Successful Launch